Metrodin Articles

Ferring expands infertility portfolio by acquiring Novartis' Norprolac

5 January 2004

Ferring gets US OK for infertility drug

13 May 2002

Puregon Solution approved by EMEA

28 April 1999

Ares-Serono Earnings Jump 64% For 1997

3 March 1998

Strong $ Hits Ares-Serono's European Growth

16 January 1998

Strong Growth At Ares-Serono

4 November 1997

FDA Clears rFSH Products From Serono, Akzo Nobel

9 October 1997

A Good Start To 1997 For Ares-Serono

5 May 1997

Ares-Serono Sales Growth Still Led By Infertility Products

27 January 1997

Strong Growth For Ares-Serono

11 November 1996

Ares-Serono's Metrodin Approved In USA

9 September 1996

1st-Half Sales Rise 15% At Ares-Serono

2 September 1996

Ares-Serono's Net Profits Surge

20 May 1996

Ares-Serono" Good Sales Growth In 1995

5 February 1996

Ares-Serono To Expand Stake In Fertility Market

11 September 1995

Shortage Of Pergonal And Metrodin In USA

20 March 1995

Italy/Spain Pull Back Ares-Serono Results

6 February 1995

Authorization For Metrodin in Germany and Ireland Questioned

24 October 1994

Italian Market Holds Down Ares-Serono

12 September 1994

ARES-SERONO TO CASH IN DIAGNOSTICS

16 May 1994

NET PROFITS FALL 32.7% AT ARES-SERONO

28 March 1994

ARES-SERONO LIFTS MARKET SHARE

29 November 1993

EC LAUNCH FOR SERONO'S METRODIN

1 November 1993

ARES-SERONO PIPELINE OVERVIEW

31 May 1993

ARES-SERONO FILES NEW rFSH SUIT

26 April 1993

SERONO ACHIEVES IVF SUCCESS WITH rhFSH

18 May 1992

ARES SERONO - HOW TO PLAY THE STOCK

11 May 1992

Showing 1-27 of 27 articles

Go to beginningPrevious
  • 1
NextGo to end